The Ethics, Cost, and Evidence Surrounding Current Pharmacological Treatment of Hepatitis C Virus Infection

被引：0
作者：
O'Malley, Patricia Anne [1 ]
机构：
[1] Miami Valley Hosp, Ctr Nursing Excellence, Premier Hlth, Dayton, OH USA
来源：
CLINICAL NURSE SPECIALIST | 2017年 / 31卷 / 04期
关键词：
DRUGS; HCV;
D O I：
10.1097/NUR.0000000000000311
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
[No abstract available]
引用
收藏
页码：186 / 188
页数：3
相关论文
共 11 条
  • [1] Appleby J., 2014, WASHINGTON POST
  • [2] Boseley Sarah., 2016, The Guardian
  • [3] Craxì L, 2016, EUR REV MED PHARMACO, V20, P1044
  • [4] HCV: the best cure possible or the best possible cure?
    Craxi, L.
    Camma, C.
    Craxi, A.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2015, 22 (08) : 627 - 629
  • [5] Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward)
    Dore, G. J.
    Ward, J.
    Thursz, M.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2014, 21 : 1 - 4
  • [6] Fleck L., 2014, MSU BIOETHICS 1023
  • [7] Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance
    Jimenez-Perez, Miguel
    Gonzalez-Grande, Rocio
    Espana Contreras, Pilar
    Pinazo Martinez, Isabel
    de la Cruz Lombardo, Jesus
    Olmedo Martin, Raul
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (29) : 6573 - 6581
  • [8] New drug for hepatitis C contributes to 13% rise in spending on prescription drugs in US
    McCarthy, Michael
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
  • [9] Pianin E., 2016, BUSINESS INSIDER
  • [10] Access to Costly New Hepatitis C Drugs: Medicine, Money, and Advocacy
    Trooskin, Stacey B.
    Reynolds, Helen
    Kostman, Jay R.
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 61 (12) : 1825 - 1830
12